RxDoctor Payments Data

Karen Paz

Physician Assistant · Palm Bay, FLNPI 1023254240

Payments from drug & device makers

$14,802in general payments, 2019–2025

Across 631 payments — averaging $23.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Merck$1K
  • Novartis$1K
  • Pfizer$872
  • Johnson & Johnson$835
  • Incyte Corporation$628
  • plus $9K from 54 others

What the payments were for

  • Food & beverage$14,34597%
  • Education$4573%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)45$1,160
Merck45$1,088
Novartis57$1,042
Pfizer35$872
Johnson & Johnson28$835
Incyte Corporation24$628
Bristol Myers Squibb40$598
AbbVie18$544
Daiichi Sankyo Inc.21$466
Seagen Inc.22$454
Lilly USA, LLC14$415
Takeda Pharmaceuticals U.S.A., Inc.16$368
Amgen(2 entities)12$356
Bayer15$305
Astellas Pharma US Inc14$297
Eisai Inc.15$290
Servier Pharmaceuticals LLC8$271
Array Biopharma Inc12$260
E.r. Squibb & Sons, L.L.C.7$259
EMD Serono, Inc.7$234
Sanofi10$232
Sobi, Inc7$219
Genentech USA, Inc.7$209
Regeneron Healthcare Solutions, Inc.8$208
Mirati Therapeutics, Inc.6$199
Karyopharm Therapeutics Inc.9$179
Exelixis Inc.7$156
Pharmacyclics LLC, An Abbvie Company6$156
Pharmacosmos Therapeutics Inc.7$152
Ipsen Biopharmaceuticals, Inc6$150
Puma Biotechnology, Inc.8$149
Gilead6$148
Taiho Oncology, Inc.7$134
Stemline Therapeutics Inc.5$117
Jazz Pharmaceuticals Inc.5$116
Pharmaessentia USA Corporation4$107
Agios Pharmaceuticals, Inc.5$101
Sumitomo Pharma America, Inc.4$98
Beone Medicines USA, Inc.4$91
Genmab U.S., Inc.3$90
G1 Therapeutics, Inc.4$84
Alnylam Pharmaceuticals Inc.4$83
Tersera Therapeutics LLC4$81
ADC Therapeutics America, Inc.4$79
Beigene USA, Inc.4$73
Deciphera Pharmaceuticals Inc.3$70
AVEO Pharmaceuticals, Inc.2$47
Geron Corporation2$46
Amneal Pharmaceuticals LLC2$44
Springworks Therapeutics, Inc.2$41
Recordati_rare_diseases_inc.2$40
GSK2$37
Caris MPI, Inc.2$35
Heron Therapeutics, Inc.2$34
Legend Biotech USA Inc.1$29
Verity Pharmaceuticals Inc.2$29
Dendreon Pharmaceuticals LLC1$27
Adaptive Biotechnologies Corporation1$25
Kyowa Kirin, Inc.1$22
Fennec Pharmaceuticals, Inc.1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,802 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$27,901
Medicare patients
151
Services billed
1,021

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban35$27,169
XareltoRivaroxaban13$12,621
CreonLipase/Protease/Amylase12$12,246
Enoxaparin Sodium16$2,494
Anastrozole111$1,608
Ondansetron OdtOndansetron22$619
Dexamethasone27$583
Prochlorperazine Maleate23$571
Hydroxyurea22$540
Gabapentin33$374
Acyclovir37$352
Hydrocortisone14$334
Levothyroxine Sodium22$326
Omeprazole23$285
Prednisone60$238

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$872$27,16935 claims
Johnson & JohnsonXarelto$835$12,62113 claims
AbbVieCreon$544$12,24612 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$44$32622 claims
Lilly USA, LLCOlanzapine$415$4212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Palm Bay

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →